Drug Markets/Vinorelbine

Vinorelbine

2 NDCs across 1 manufacturer|2 Generic,0 Brand

Vinorelbine is used to treat breast neoplasms, non-small-cell lung carcinoma, hodgkin disease and ovarian neoplasms, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Vinorelbine is available as 2 NDCs from 1 manufacturer (2 generic, 0 brand), with NADAC prices from $17.06 to $18.96 per ML — a 11% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

2

2G / 0B

Manufacturers

1

competing in market

Price Spread

$17.06 – $18.96

per ML

7d Activity

2 flat

avg +0.0% WoW · of 2 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing VINORELBINE

Drug Portfolio

2 NDCs total, 2 shown

Drug ↕Price 7d Change ↕
VINORELBINE 10 MG/ML VIAL
$18.9617
per ML
—
VINORELBINE 50 MG/5 ML VIAL
$17.0583
per ML
—

Frequently Asked Questions

What is Vinorelbine used to treat?

Vinorelbine is used to treat breast neoplasms, non-small-cell lung carcinoma, hodgkin disease and ovarian neoplasms, per the National Library of Medicine's MED-RT classification.

How many Vinorelbine products are on the market?

The Vinorelbine drug market contains 2 NDCs from 1 manufacturer — 2 generic and 0 brand products.

What is the price range for Vinorelbine?

NADAC reference prices for Vinorelbine range from $17.0583 to $18.9617 per ML — a 11% difference between cheapest and most expensive.

Which manufacturers make Vinorelbine?

1 manufacturer lists Vinorelbine in NADAC. Ranked by number of NDCs, the largest are Sagent Pharmaceuticals (2).